QID 50121

Date Published: 2022-08-10

QID 50121: Microsoft Exchange Server Elevation of Privilege Vulnerability for August 2022

Microsoft Exchange Server is prone to multiple vulnerabilities:

Microsoft Exchange Server Elevation of Privilege Vulnerability
KB Articles associated with this update are: KB5015321, KB5015322

Affected Versions:
Microsoft Exchange Server 2013 Cumulative Update 23
Microsoft Exchange Server 2019 Cumulative Update 11
Microsoft Exchange Server 2019 Cumulative Update 12
Microsoft Exchange Server 2016 Cumulative Update 23
Microsoft Exchange Server 2016 Cumulative Update 22
QID Detection Logic (authenticated):
The QID checks for the version of file Exsetup.exe.

Successful exploitation allows Elevation of privilege.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as High - 7.2 severity.
    • Solution
    Customers are advised to refer to KB5015321 KB5015322 for information pertaining to this vulnerability.
    Vendor References

    CVEs related to QID 50121

    CVE-2022-30134 | CVE-2022-21979 | CVE-2022-21980 | CVE-2022-24516 | CVE-2022-24477 |
    Software Advisories
    Advisory ID Software Component Link
    KB5015321 URL Logo support.microsoft.com/en-us/topic/description-of-the-security-update-for-microsoft-exchange-server-2013-august-9-2022-kb5015321-96a47598-09b7-43eb-98bb-76fdf906f265
    KB5015322 URL Logo support.microsoft.com/en-us/topic/description-of-the-security-update-for-microsoft-exchange-server-2019-and-2016-august-9-2022-kb5015322-86c06afb-97df-4d8f-af88-818419db8481
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].